What Researchers Did
This study retrospectively analyzed 52 adult patients with skull base osteomyelitis (SBO) to evaluate how effective antibiotic therapy is when used as part of a comprehensive treatment plan that also included surgery and hyperbaric oxygen therapy.
What They Found
Researchers found that 55.8% of the 52 patients with skull base osteomyelitis received hyperbaric oxygen therapy, while 71.2% underwent surgery. The average duration of intravenous antibiotics was 31.9 days, and despite repeated sampling, no pathogen was identified in 19.2% of patients.
What This Means for Canadian Patients
Canadian patients with skull base osteomyelitis may benefit from a comprehensive treatment approach that includes individualized antibiotic therapy, surgery, and hyperbaric oxygen therapy. This study highlights the importance of accurate pathogen identification through tissue sampling to guide effective treatment for this serious infection.
Canadian Relevance
This study was not conducted by Canadian authors or in Canada, and skull base osteomyelitis is not a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
The study's retrospective design and relatively small sample size of 52 patients limit the generalizability of its findings.